Search / Trial NCT06225986

Living Memory Home-4-Dementia Care Pairs

Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Jan 17, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

The Living Memory Home-4-Dementia Care Pairs trial is studying an online program designed to help people with dementia and their family caregivers connect by sharing and recording meaningful memories. The main goals of this study are to see how easy and helpful the program is for participants, and to find out if it can help reduce feelings of grief in caregivers and improve their relationships with their loved ones.

To be eligible for this study, family caregivers must be the primary caretaker of someone in the early to moderate stages of dementia, be at least 18 years old, and speak English. They should also be able to use the internet. Participants will log in to the online platform and complete activities three times a week for a month. Researchers will then compare the results from those using the program to a control group to see if the program has positive effects. This study is currently recruiting participants, so if you or someone you know fits the criteria, it might be a great opportunity to find support and strengthen connections.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Family Caregivers:
  • be a primary source of care for a family member in the early to moderate stages of dementia
  • 18 years of age or older
  • English-speaking
  • does not exhibit cognitive impairment (e.g., scoring \< 3 on the SPMSQ)
  • able to use the internet and has internet access.
  • PwD
  • if the caregiver deems the PwD able
  • the PwD scores \< 8 on the Short Portable Mental Status Questionnaire (SPMSQ)
  • demonstrates capacity to consent to a low-risk study as indicated by a score of ≥9 on the University of California-San Diego Brief Assessment of Capacity to Consent.
  • Exclusion Criteria:
  • Family Caregivers:
  • is not the primary family caregiver of the PwD
  • under the age of 18-years-old
  • exhibits cognitive impairment (by scoring 3 or more on the SPMSQ)
  • does not speak English as a primary language.
  • PwD:
  • severe cognitive impairment detected by the clinical or study staff using validated, brief screening tools (e.g., a score of 8 errors or more on the SPMSQ)
  • does not demonstrate capacity to consent (e.g., a score of 9 or fewer errors on the University of California-San Diego Brief Assessment of Capacity to consent
  • PwD is living in a long-term care facility
  • does not speak English as a primary language
  • is under the age of 18 years-old.

Trial Officials

Holly Prigerson, PhD

Principal Investigator

Weill Medical College of Cornell University

Francesca Falzarano, PhD

Principal Investigator

University of Southern California; Weill Cornell Medicine

About Weill Medical College Of Cornell University

Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.

Locations

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0